Your browser doesn't support javascript.
loading
Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer.
Sasada, Shinsuke; Kondo, Naoto; Hashimoto, Hiroya; Takahashi, Yuko; Terata, Kaori; Kida, Kumiko; Sagara, Yasuaki; Ueno, Takayuki; Anan, Keisei; Suto, Akihiko; Kanbayashi, Chizuko; Takahashi, Mina; Nakamura, Rikiya; Ishiba, Toshiyuki; Tsuneizumi, Michiko; Nishimura, Seiichiro; Naito, Yoichi; Hara, Fumikata; Shien, Tadahiko; Iwata, Hiroji.
Afiliación
  • Sasada S; Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
  • Kondo N; Department of Breast Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Hashimoto H; Core Laboratory, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Takahashi Y; Department of Breast and Endocrine Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Kitaku, 700-8558, Okayama, Japan.
  • Terata K; Department of Breast and Endocrine Surgery, Akita University Hospital, Akita, Japan.
  • Kida K; Department of Breast Surgical Oncology, St. Luke's International Hospital, Tokyo, Japan.
  • Sagara Y; Department of Breast and Thyroid Surgical Oncology, Social medical corporation Hakuaikai, Sagara Hospital, Kagoshima, Japan.
  • Ueno T; Breast Oncology Center, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Anan K; Department of Surgery, Kitakyushu Municipal Medical Center, Kitakyushu, Japan.
  • Suto A; Department of Breast Surgery, National Cancer Center Hospital, Tokyo, Japan.
  • Kanbayashi C; Department of Breast Oncology, Niigata Cancer Center Hospital, Niigata, Japan.
  • Takahashi M; Department of Breast Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan.
  • Nakamura R; Department of Breast Surgery, Chiba Cancer Center, Chiba, Japan.
  • Ishiba T; Department of Breast Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Tsuneizumi M; Department of Breast Surgery, Shizuoka General Hospital, Shizuoka, Japan.
  • Nishimura S; Department of Breast Surgery, Shizuoka Cancer Center Hospital, Shizuoka, Japan.
  • Naito Y; Department of General Internal Medicine, National Cancer Center Hospital East, Chiba, Japan.
  • Hara F; Breast Oncology Center, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Shien T; Department of Breast and Endocrine Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Kitaku, 700-8558, Okayama, Japan. tshien@md.okayama-u.ac.jp.
  • Iwata H; Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
Breast Cancer Res Treat ; 202(3): 473-483, 2023 Dec.
Article en En | MEDLINE | ID: mdl-37688665
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Breast Cancer Res Treat Año: 2023 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Breast Cancer Res Treat Año: 2023 Tipo del documento: Article País de afiliación: Japón